Cerity Partners’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183K Buy
52,299
+242
+0.5% +$871 ﹤0.01% 2900
2025
Q4
$178K Sell
52,057
-1,000
-2% -$4.46K ﹤0.01% 2667
2025
Q3
$267K Hold
53,057
﹤0.01% 2358
2025
Q2
$182K Hold
53,057
﹤0.01% 2379
2025
Q1
$118K Hold
53,057
﹤0.01% 2304
2024
Q4
$145K Hold
53,057
﹤0.01% 2290
2024
Q3
$138K Buy
53,057
+32,500
+158% +$90.1K ﹤0.01% 2387
2024
Q2
$60.8K Sell
20,557
-18,000
-47% -$68.1K ﹤0.01% 2158
2024
Q1
$175K Buy
38,557
+18,000
+88% +$91.8K ﹤0.01% 2135
2023
Q4
$117K Hold
20,557
﹤0.01% 1773
2023
Q3
$94.6K Hold
20,557
﹤0.01% 1334
2023
Q2
$133K Buy
+20,557
New +$140K ﹤0.01% 1524
2021
Q3
Sell
-17,000
Closed -$374K 683
2021
Q2
$374K Buy
+17,000
New +$469K 0.01% 527

Other funds holding ABCL